Treating lymphoma or leukemia in a patient comprises modulating the level of an expression product of a gene selected from PI3KR1, GNAS, NESP5, JAK1, neurogranin, HIPK1, or Nrf2

Research output: Patent

  • Interdisciplinary Nanoscience Center
  • Department of Molecular Biology
Original languageEnglish
IPCA61K-039/395
Patent numberUS2007098728-A1
Filing date03/05/2007
CountryUnited States
Publication statusPublished - 2007

See relations at Aarhus University Citationformats

ID: 10529279